Reinforcing effect of subcutaneous morphine in a modified ettenberg runway
Tóm tắt
Alley running has been successfully used as an operant to demonstrate both the positive and negative reinforcing effect of intravenously administered drugs of abuse in a bona fide operant conditioning paradigm, the Ettenberg runway, in which confounding drug effects on motor performance and drug accumulation are avoided. While Ettenberg and colleagues focus on the intravenous route of drug administration, we tested the practicability of the subcutaneous route of administration in this runway paradigm in Sprague Dawley rats, using morphine as the investigated drug of abuse. We also modified the Ettenberg runway, most notably in that either food (sweetened condensed milk), no food, morphine, or saline was presented outside the runway in a separate cage. This made shaping, i.e., the initial presentation of a food reinforcer within the runway, necessary to establish responding. The manipulations necessary to administer subcutaneous (sc) injections were well tolerated by over 90% of the tested rats (n=93). However, sc injections increased runtimes to the experimenter cutoff of 60 s within 20 once-daily sessions. Because of strong experimenter effects, all morphine doses or saline had to be administered blind. Under these experimenter-blind conditions, 0.1 and 1 mg/kg subcutaneous morphine proved to be reinforcing in that these doses significantly slowed down the gradual increase in runtimes imposed upon by the sc injection procedure. Thus, morphine can be demonstrated to be a positive reinforcer in a modified Ettenberg runway even when given subcutaneously. This effect, however, is eventually overcome by the negative reinforcing effect of subjecting the animals to sc injection procedure.
Tài liệu tham khảo
Ettenberg A. and Geist T. D. (1991) Animal model for investigating the anxiogenic effects of self-administered cocaine. Psychopharmacology 103, 455–461.
Geist T. D. and Ettenberg A. (1990) A simple method for studying intravenous drug reinforcement in a runaway. Pharmacol. Biochem. Behav. 36, 703–706.
Geist T. D. and Ettenberg A. (1997) Concurrent positive and negative goalbox events produce runway behaviors comparable to those of cocaine-reinforced rats. Pharmacol. Biochem. Behav. 57, 145–150.
Lamb R. J., Preston K. L., Schindler C. W., et al. (1991) The reinforcing and subjective effects of morphine in post-addicts: A dose-response study. J. Pharmacol. Exp. Ther. 259, 1165–1173.
McFarland K. and Ettenberg A. (1997) Reinstatement of drug-seeking behavior produced by heroinpredictive environmental stimuli. Psychopharmacology 131, 86–92.
McFarland K. and Ettenberg A. (1998) Haloperidol does not affect motivational processes in an operant runway model of food-seeking behavior. Behav. Neurosci. 112, 630–635.
Mello N. K. and Negus S. S. (1996) Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures. Neuropsychopharmacology 14, 375–424.
Oittinen H., Rameis H., Saria A., and Zernig G. (2001) Lack of a reinforcing effect of the benzodiazepine-tricyclic antidepressant-combination diazepam-dothiepin. Pharmacology 62, 124–128.
Ratzenboeck E., Saria A., Kriechbaum N., and Zernig G. (2001) Reinforcing effects of 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) in drugnaive and cocaine-trained rats. Pharmacology 62, 138–144.
Schuster C. R. and Johanson C. E. (1981) An analysis of drug-seeking behavior in animals. Neurosci. Biobehav. Rev. 5, 315–323.
White N., Sklar L., and Amit Z. (1977) The reinforcing action of morphine and its paradoxical side effect. Psychopharmacology 52, 63–66.
White N. M. (1996) Addictive drugs as reinforcers: multiple partial actions on memory systems. Addiction 91, 921–949.
Woods J. H. (1989) Narcotic-reinforced responding: a rapid evaluation procedure. Drug Alcohol Depend. 5, 223–230.
Zernig G., Lewis J. W., and Woods J. H. (1997) Clocinnamox inhibits the intravenous self-administration of opioid agonists in rhesus monkeys: Comparison with effects on opioid agonist-mediated antinociception. Psychopharmacology 129(3), 233–242.